Specific destruction of ciliated epithelial cells lining the large airways is the primary respiratory tract cytopathology associated with human Bordetella pertussis infections. We have purified a single low-molecularweight glycopeptide, tracheal cytotoxin (TCT), that appears to cause this pathology. By using a combination of solid-phase extraction and reversed-phase high-pressure liquid chromatography, about 700 nmol of biologically active peptide can be isolated from 1 liter of B. pertussis culture supernatant (approximately 60% yield). TCT at concentrations of 1 ,uM destroyed the ciliated cell population when incubated with respiratory epithelium in vitro. This concentration of TCT is similar to the concentrations found in the culture supernatant of growing B. pertussis. Purified TCT also inhibited DNA synthesis of hamster trachea epithelial cells in a quantitative, dose-dependent fashion. Endotoxin was not detected in the purified material, and neither B. pertussis nor Escherichia coli endotoxin could duplicate the biological activities of TCT. Amino acid and amino sugar analyses of purified TCT revealed the presence of glucosamine, muramic acid, alanine, glutamic acid, and diaminopimelic acid in molar ratios of 1:1:2:1:1. This suggests that TCT, the released ciliostatic principle of B. pertussis, is a disaccharide tetrapeptide subunit of peptidoglycan.
Bordetella pertussis is a gram-negative bacterium that causes the human respiratory tract illness known as whooping cough (or pertussis). The characteristic pathology associated with the disease, which features specific bacterial colonization of and destruction of ciliated cells, was first described three-quarters of a century ago by Mallory and Horner (19) . The consequences of this cytopathology can be severe, because the loss of ciliary activity significantly impairs mucus transport out of the respiratory tract. Accumulation of mucus, multiplying bacteria, and inflammatory debris in the absence of a functional mucociliary "escalator" give rise to a situation where coughing is the only remaining means to clear the blocked airways. Therefore, damage to the ciliated cells may generate the paroxysmal coughing episodes characteristic of pertussis as well as predispose the infected host to secondary pulmonary infections (24) .
The cytopathological events during B. pertussis infection of the respiratory tract have been studied by using tracheal organ culture as an in vitro model system (7) . With tracheal rings dissected from hamsters, infection with B. pertussis is similar to that in humans: a noninvasive, specific colonization of ciliated cells, followed by ciliostasis and the eventual extrusion of the ciliated cell population (23) . Although there are a variety of biologically active virulence-associated macromolecules produced by B. pertussis (for a review, see reference 32), only a low-molecular-weight fraction of bacterial culture supernatant can mimic this ciliated-cell-specific pathology when incubated with tracheal organ cultures (15) .
Furthermore, hamster trachea epithelial (HTE) cells (13) , to which virulent B. pertussis can adhere, are unable to synthesize DNA in the presence of viable B. pertussis. This effect on HTE cells can be reproduced by the addition of the same low-molecular-weight fraction of culture supernatant that destroys tracheal organ culture (15) . We speculate that this inhibitory activity of B. pertussis may delay the normal replacement of destroyed ciliated cells in vivo by blocking division and differentiation of the underlying regenerative * Corresponding author.
basal cell population (18) . This notion is consistent with the observation that the clinical course of pertussis is unchanged by antibiotic therapy initiated after the onset of coughing paroxysms (24) . Viable B. pertussis organisms are no longer present, yet manifestations of active infection, including the coughing episodes, can continue for weeks.
To understand more fully the ciliated-cell-specific pathology that results from B. pertussis infections, we sought to purify the tracheal cytotoxin (TCT) activity of culture supernatants to homogeneity. Here we report the isolation and composition of TCT-a single molecule produced by B. pertussis that specifically destroys ciliated respiratory epithelial cells.
MATERIALS AND METHODS Bacteria. Virulent phase I B. pertussis Tohama I was stored at -70°C in a solution containing Casamino Acids (Difco Laboratories, Detroit, Mich.), MgCI2, CaCl2, and NaCl with 50% glycerol (30) . Bacteria were grown on solid modified Stainer-Scholte medium (SSM) (16, 31) supplemented with 10% fresh defibrinated sheep blood in Alsevers (GIBCO Laboratories, Grand Island, N.Y.) by incubating at 37°C for 72 h in a humidified atmosphere containing 95% air-5% CO2. We used the resulting growth to inoculate liquid medium consisting of SSM containing 10% Casamino Acids. After incubation on a rotary shaker (150 rpm) at 37°C for 24 to 48 h in an atmosphere of 95% air-5% C02, the latelog-phase cells were harvested by centrifugation (15 4 .6-mm (inner diameter) column containing 7-,um spherical particles of C8-derivatized silica with a solvent delivery rate of 1 ml/min. UV-absorbing components of the column effluent were detected at 214 nm by using a Spectroflow 757 variable-wavelength UV detector (Kratos, Ramsey, N.J.), and peak areas and retention times were recorded by using a Hitachi Model D-2000 ChromatoIntegrator (Hitachi, Ltd., Tokyo, Japan). We collected peaks of interest in borosilicate glass tubes and stored them at -70°C after removal of the volatile mobile phase by rotary evaporation. For making mobile phases, we filtered all solvents with a Millipore all-glass filtration apparatus with Durapore 0.45-,um-pore-size membranes (Millipore Corp., Bedford, Mass.) and degassed the acetonitrile, methanol, and purified water before mixing. All organic reagents were HPLC/Spectro grade (Pierce Chemical Co., Rockford, Ill.), and water was distilled and deionized (NANOpure; Barnstead Co., Newton, Mass.).
Two distinct chromatographic systems were employed to purify TCT from solid-phase extracts: reversed-phase HPLC by gradient elution with methanol in a triethylamine acetate (TEA-acetate)-buffered mobile phase and gradient elution with acetonitrile in a TFA-buffered mobile phase. The TEAacetate buffer was prepared as described by Matrisian et al. (21) , except that a 0.01 M acetic acid solution was brought to pH 5.55 by the addition of triethylamine. The aqueous portion of the mobile phase (solution A) consisted of 0.01 M TEA-acetate (pH 5.55), and solution B consisted of solution A containing methanol at a final concentration of 30% (voUvol). In the TEA-acetate-buffered system, a convex gradient from 0 to 7.5% methanol developed over a period of 30 min. This gradient was preceded by a 5-min isocratic loading and washing interval with A and followed by a 3-min isocratic elution with 3A:1B. Subsequent purging with B for 5 min removed any adsorbed molecules remaining on the column, and equilibration with A for at least 20 min before another sample injection insured reproducible chromatography.
For the TFA-buffered system, solution A consisted of 0.1% TFA in water (pH approximately 3), and solution B consisted of solution A plus acetonitrile at a final concentration of 30% (vol/vol). A linear gradient from 0 to 9.0% acetonitrile proceeded over an interval of 30 min. Other aspects of the TFA system were similar to those of the TEA-acetate system. In both buffer systems we found it to be extremely important that Assessment of biological activity. HTE cells were isolated and cultured as described previously (13) , except that we used 9 ,ug of gentamicin per ml instead of penicillin and streptomycin. HTE cells were harvested from nearly confluent monolayers, seeded at 1.5 x 104 cells per microtiter well in bicarbonate-buffered minimal essential medium containing 2.5% fetal bovine serum (HyClone, Logan, Utah), and incubated for 24 h at 37°C in a humidified environment containing 95% air-5% CO2. We removed the medium from each well with gentle suction and replaced it with the appropriate control or test samples dissolved in 5 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-buffered minimal essential medium (pH 7.3). Purified TCT was added in the presence of bovine serum albumin as a protein protectant and carrier; control samples also included bovine serum albumin. After incubation for 4 h at 370C in a humidified environment (without C02), the DNAsynthetic ability of sample-treated cells and untreated control cells was quantitated by measuring [3H]thymidine incorporation after serum stimulation as described previously (15 rings manually (6) 
RESULTS
Extraction of TCT from culture supernatants. To devise an effective purification scheme, we chose solid-phase extraction to prepare samples for more rigorous isolation procedures. In the first step of a rapid method, we used a reversed-phase matrix (C18) to concentrate tracheal cytotoxic activity from the culture supernatant of B. pertussis growing in the mid-to late-log phase. Once the supernatant had been acidified and passed through the C18 Sep-Pak, nonspecifically bound substances were washed away and adsorbed molecules were selectively eluted by the addition of 0.1% TFA in water containing 20% n-propyl alcohol. Under these conditions, a peptide-rich fraction can be obtained that is free of large polypeptides, salts, and free amino acids (2) (3) (4) 29) . HPLC analysis of this relatively complex extract revealed the presence of one peak with cytotoxic activity (Fig. 1A) .
Amino acid analysis of partially purified material suggested that TCT may have significant anionic or acidic character. Therefore, anion exchange was chosen to fractionate acidic molecules from basic and/or neutral molecules present in the TCT-enriched eluate from the C18 extraction. The C18 extract was loaded onto the strong anion-exchange QMA Sep-Pak in low-salt running buffer (pH 5.5) and washed with the same to remove any nonspecifically bound components. Adsorbed molecules with presumed anionic character were then eluted from the QMA Sep-Pak with high-salt elution buffer, also at pH 5.5. Optimal extraction of toxic activity into the eluted fraction occurred at pH 5.5; a lower pH resulted in decreased recovery, whereas a higher pH increased the proportion of contaminating molecules harvested without a significant increase in yield. Figure 1B shows a typical chromatogram of the UV-absorbing components in the effluent from this ion-exchange solid-phase extraction. Comparison of the HPLC profiles of the C18 (Fig.  1A) and QMA (Fig. 1B) extracts indicates that the complexity of the fraction containing activity has been significantly reduced and that several components with HPLC retention times similar to the peak with cytotoxic activity have been removed.
Purification of TCT from culture supernatant extracts. TCT was completely purified from the ion-exchange extract described above by using two successive reversed-phase HPLC separations. First, the QMA eluate was loaded onto a C8 column in TEA-acetate buffer (pH 5.55) and separated by gradient elution with methanol. A typical chromatogram resulting from this purification step is shown in Fig. 2A . Amino acid analysis of the biologically active fraction (data not shown) indicated that the TEA-acetate system effectively separated TCT from other acidic peptides contained in the ion-exchange extract; however, nonproteinaceous, UVabsorbing contaminants were present in the collected material. To separate TCT from these contaminating molecules, the concentrated eluate containing activity from the TEAbuffered HPLC separation was subjected to reversed-phase HPLC in a TFA-buffered system (Fig. 2B) . The single harvested peak from this procedure was homogeneous, free of all contaminants, and biologically active (see below). It should be noted that throughout purification the only fractions capable of destroying ciliated respiratory epithelium contained this peak. Table 1 summarizes a typical purification of TCT from 25 ml of mid-log-phase B. pertussis Tohama I culture supernatant. The effectiveness of this protocol was evaluated by determining the amount of biological activity present in a sample after each step (see below). About 700 nmol of TCT could be purified from 1 liter of culture supernatant in high yield (63%), indicating that TCT was present in supernatants at a concentration in excess of 1 F.M.
Biological activity. Dose-dependent inhibition of DNA synthesis in HTE cells was used as a method of quantitatively measuring TCT activity. This activity is also present in the toxic fractions that cause ciliated-cell-specific cytopathology in tracheal organ cultures. Using both organ culture and HTE cells as biological test systems for the material purified by the HPLC-based protocol, we proved that both activities of B. pertiussis culture supernatants are due to intoxication by the same molecule. Ciliary activity in hamster tracheal rings was completely annihilated after 96 h of (26) . incubation with purified TCT at 1 F.M and after 48 to 72 h when incubated with 3 ,uM TCT. Figure 3 is a representative dose-response curve showing inhibition of DNA synthesis in HTE cells by purified TCT. A threshold for an inhibitory response was observed, and maximal inhibition occurred at concentrations of about 1 F.M. This is in contrast to the lower specific activity and more shallow dose-response curve reported with less purified material (14, 15) . We attribute this improved biological activity to the removal of contaminating molecules interfering with this assay for tracheal cytotoxic activity. Importantly, TCT is found in B. pertussis culture supernatants at concentrations sufficient to elicit the destruction of respiratory epithelium (see above).
To establish that the observed biological responses were in fact due to TCT and not to contaminating endotoxin, test samples were evaluated for the presence of endotoxin by using the Limulus amebocyte lysate assay. No detectable endotoxin (<10 fg per 6.5 ,ug of TCT) was present in samples that had been subjected to either TFA-or TEA-buffered reversed-phase HPLC. In C18 solid-phase extracts of B. pertussis culture supernatants, we detected endotoxin concentrations as high as 10 ng/ml. However, purified B. pertussis or E. coli endotoxin at concentrations as high as 0.1 p.g/ml neither inhibited DNA synthesis of HTE cells nor caused ciliated-cell-specific cytopathology in organ cultures (data not shown). This strongly suggests that contaminating endotoxin is not responsible for the biological activities described above for purified TCT. Composition. To characterize further the biologically active material, we subjected samples of TCT to amino acid and amino sugar analyses ( Table 2 ). The previously reported This analytical system can resolve various classes of peptidoglycan fragments in addition to TCT, the major fragment released by growing B. pertussis (26) . Although the VOL. 57, 1989 on October 28, 2017 by guest http://iai.asm.org/ Downloaded from released material represents only a small percentage of the macromolecular peptidoglycan of B. pertussis organisms, our experiments show that TCT is produced at levels sufficient to evoke significant biological effects. Since TCT is undetectable by pulse-chase-type experiments designed to look at turnover of macromolecular peptidoglycan (25, 28) , detecting soluble fragments released by bacterial microorganisms may require more direct methods (like those described here). The use of HPLC to separate fragments of purified peptidoglycan has been reported by workers in several laboratories (8, 11, 20) , but its use has been limited to the analysis of enzymatic digestions of high-molecularweight cell wall material precipitated by hot sodium dodecyl sulfate. TCT, for instance, is refactory to commonly used protein precipitation procedures (unpublished observations). This suggests that implementation of solid-phase extraction to harvest peptide extracts would greatly expedite the analysis of solutions thought to contain soluble peptidoglycan fragments. This technique could be widely applicable to avenues of research such as the investigation of other mucosal pathogens for production of TCT or TCT-like molecules, the detection of peptidoglycan in host tissue (see below), the analysis of antibiotic-induced bacterial autolytic products, and the study of recycling of peptidoglycan for new cell wall synthesis in bacteria.
The peptidoglycan-derived composition of TCT establishes that it is one of the muramyl peptides (muramic acid-containing glycopeptides), a family of molecules with diverse biological activities. Well-documented effects of these molecules include pyrogenicity, adjuvanticity, arthritogenicity, stimulation of leukocytes to produce interleukin-1, and induction of slow-wave sleep (for reviews, see references 1, 5, and 17). Of particular interest is the observation that Neisseria gonorrhoeae releases anhydromuramic acidcontaining disaccharide peptides (27, 28) that are capable of causing ciliated-cell-specific damage to fallopian tube mucosa (22) . Results reported here and our collaborative work with Rosenthal et al. (26) indicate that TCT has an analogous disaccharide-tetrapeptide arrangement. Presumably TCT is derived from macromolecular Bordetella peptidoglycan, the end product of a multigene biosynthetic pathway. We therefore conclude that TCT is not a clonable gene product and that biochemical approaches will be necessary to elucidate further the pathobiological roles of TCT in disease. We have accomplished the first step of such an approach by developing a rapid method of isolating completely purified and biologically active TCT in high yield. Homogeneous material will allow us to look at host cell receptors and/or target sites through which TCT exerts its toxic effects on respiratory epithelium. Armed with powerful separation and analysis tools and the appropriate biological model systems, we are now exploring the toxic effects of TCT on epithelia.
